Scottish Pharmacy Board election 2019
The scheme for the 2019 election provides for three places on the Royal Pharmaceutical Society Scottish Pharmacy Board for Members or Fellows who work or live wholly or mainly in Scotland. Full details of eligibility criteria are set out at https://www.rpharms.com/about-us/who-we-are/national-boards/boards-elections.
Nominations for candidates in the Scottish Pharmacy Board election cannot be made until 14 March 2019 and must be made on the form issued by the independent scrutineer, Mi-Voice, or on-line via the Mi-Voice website www.mi-nomination.com/rpharms. Alternatively nominations may be submitted by post or by hand to Mi-Voice, Epsilom House, Enterprise Road, Chilworth Science Park, Southampton, SO16 7NS. For further information please contact Mi-Voice Support on 02380 763980.
Any nomination must be signed by three Member nominators whose own address on the Society’s database is in Scotland or overseas. Members who nominate candidates must have completed 2019 Membership processes. A Member or Fellow who is resident overseas at the time the electoral roll is closed shall be entitled to nominate a candidate for the English Pharmacy Board unless he or she has opted to be an elector of one of the other national pharmacy boards.
Nominations for election to these vacancies must be received by 17:00 on 4 April 2019. A nomination may be withdrawn by notice in writing, signed by the prospective candidate and delivered to email@example.com or Mi-Voice, Gamma House, Enterprise Road, Chilworth Science Park, Southampton, SO16 7NS, no later than 17:00 on 5 April 2019.
Periods of office
Board members are elected for a three-year period.
It is expected that voting papers will be emailed (or posted if requested by 5 April) to the electorate on or about 29 April 2019. The deadline for voting (either online or by post) will be 17:00 on 16 May 2019. Newly elected board members will take office at 00.01 on 2 July 2019.
Alex MacKinnon, returning officer for Scotland
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206167
Recommended from Pharmaceutical Press